GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Insurance INS

Support legislation to continue funding for the Child Health Insurance Program.

Contacted: Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Homeland Security, Dept of (DHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office

Health Issues HCR

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller bill, and the FY 2017 budget resolution (S. Con. Res. 3). Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Provided comments to SAMHSA regarding its final rule modifying the regulations at 42 CFR Part 2. Advocate for continuation of ACA CSR subsidy payments. Support for streamlining HIPAA requirements in a letter to the HHS Office for Civil Rights. Comments on the FY 2018 IPPS proposed rule (CMS-1677-P) re: electronic health record incentive program modifications. Educated staff from the Office of Civil Rights at HHS about the complexities of Federal and State HIPAA and privacy laws and how they inhibit legitimate information sharing.

Contacted: Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); White House Office; Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 3 (115th), H.R. 1628 (115th)

Medicare/Medicaid MMM

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and the Better Care Reconciliation Act (Senate) (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (support) (H.R.2267/S.1301). Oppose the continuation of Medicaid Disproportionate Share Hospital (DSH) cuts. The Empire State Equity Act (H.R. 2088) - support. Provide comments to CMS on the Medicare IPPS FY 2018 proposed rule (CMS-1677-P), advocate for a delay of proposed rule section dealing with DSH uncompensated care pool, and comments regarding Medicare quality reporting program proposals. Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose. Oppose legislation and regulations that would harm 340B program, including proposal in the 2018 proposed OPPS rule (CMS-1678-P) reducing Medicare reimbursment for certain 340B drugs. Provided comments to CMS on the 2018 OPPS proposed rule (CMS-1678-P) addressing payments to off-campus hospital outpatient departments. Support Federal funding for Puerto Rico's Medicaid program and for Medicaid for individuals and families displaced by hurricanes (H.R.2266 - Additional Supplemental Appropriations for Disaster Relief Requirements Act, 2017, H.R.601 - Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017.) Discussed impediments to hospitals becoming teaching hospitals due to complex GME rules with CMS staff.

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); White House Office; Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Homeland Security, Dept of (DHS)

Bills named: H.R. 2267 (115th), S.Con.Res. 3 (115th), H.R. 1628 (115th), H.R. 2266 (115th), S. 1301 (115th), H.R. 601 (115th), H.R. 2088 (115th)

Pharmacy PHA

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases, including raising awareness about saline shortages. Oppose legislation that would harm the 340B drug discount program for safety net hospitals, and support legislation (H.R.4392) that prevents the implementation of 340B reductions finalized in the CMS outpatient rule (CMS-2017-0091). Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214), and support other pro-competition policies, including legislation that would prohibit evergreening and abuse of citizen petitions, and promote the growth of biosimilars.

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); White House Office; Health Resources & Services Administration (HRSA)

Bills named: S. 944 (115th), S. 124 (115th), H.R. 4392 (115th), H.R. 2214 (115th)

Taxation/Internal Revenue Code TAX

Oppose provisions contained in the Tax Cuts and Jobs Act (H.R. 1), including provisions related to private activity bonds, the individual insurance mandate repeal, executive compensation, medical deductions, education and child care exclusions, and state and local tax deductibility.

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); Homeland Security, Dept of (DHS); White House Office; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1 (115th)

Immigration IMM

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

Contacted: SENATE; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); White House Office; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Homeland Security, Dept of (DHS)

Budget/Appropriations BUD

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and Better Care Reconciliation Act (Senate) (budget reconciliation bill, H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Oppose funding cuts for the NIH included in President Trumps FY 18 budget proposal (America First: A Budget Blueprint to Make America Great Again). Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose.

Contacted: Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); White House Office; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1628 (115th), S.Con.Res. 3 (115th)